DSM to sell participation in DEXPlastomers JV to Borealis

DSM to sell participation in DEXPlastomers JV to Borealis 
HEERLEN, NETHERLANDS -- (Marketwire) -- 11/12/12 --  Royal DSM, the
global Life Sciences and Materials Sciences company, announced today
that it has reached an agreement with Borealis AG for the sale of
DEXPlastomers V.o.F, a 50/50 Joint Venture of DSM with an affiliate
of ExxonMobil Chemical. DSM will also sell its LldPE Compact Solution
Technology to Borealis. Subject to customary approvals and
notifications, the transaction is
expected to close in Q1 2013. 
Established in 1996, DEXPlastomers is a 50/50 joint venture between
DSM and Exxon Chemical Holland Ventures B.V., producing C8 plastomers
and linear low
density polyethylene.  DSM's LldPE Compact Solution
Technology was developed in the 1960's to produce polyethylenes in a
certain density range and is instrumental to the operations of
In 2012, DEXPlastomers anticipates sales of approximately EUR180
million. Currently, 95 DSM employees are in the scope of the
For DSM, a sale of DEXPlastomers is in line with its long-term focus
of being a Life Sciences and Materials Sciences company, active in
health, nutrition and
materials. DSM's 50% participation in
DEXPlastomers is reported under Corporate
Activities in DSM's
DSM - Bright Science. Brighter Living.(TM) 
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in Life
Sciences and Materials
Sciences DSM is driving economic prosperity,
environmental progress and social
advances to create sustainable
value for all stakeholders. DSM delivers innovative solutions that
nourish, protect and improve performance in global
markets such as
food and dietary supplements, personal care, feed, pharmaceuticals,
medical devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio-based materials. DSM's
employees deliver annual net sales of around EUR9 billion. The
company is listed on NYSE Euronext. More information can be found at
Press release-pdf: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the 
releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: DSM N.V.  via Thomson Reuters ONE 
DSM Corporate Communications
Herman Betten
tel. +31 (0) 45 5782017
fax +31 (0) 45 5740680
DSM Investor Relations
Dave Huizing
tel. +31 (0) 45 5782864
fax +31 (0) 10 4590275
Press spacebar to pause and continue. Press esc to stop.